A scalable, clinically severe pig model for Duchenne muscular dystrophy

Stirm, M.; Fonteyne, L. M.; Shashikadze, B.; Lindner, M.; Chirivi, M.; Lange, A.; Kaufhold, C.; Mayer, C.; Medugorac, I.; Kessler, B.; Kurome, M.; Zakhartchenko, V.; Hinrichs, A.; Kemter, E.; Krause, S.; Wanke, R.; Arnold, G. J.; Wess, G.; Nagashima, H.; Hrabe de Angelis, M.; Flenkenthaler, F.; Kobelke, L. A.; Bearzi, C.; Rizzi, R.; Baehr, A.; Matiasek, K.; Walter, M. C.; Kupatt, C.; Ziegler, S.; Bartenstein, P.; Froehlich, T.; Klymiuk, N.; Blutke, A.; Wolf, E.

doi:10.1101/2021.09.01.457562

Home/Archive/bioRxiv

bioRxiv · 10.1101/2021.09.01.457562

A scalable, clinically severe pig model for Duchenne muscular dystrophy

View original source ↗Export metadata ↓

Abstract

Large animal models for Duchenne muscular dystrophy (DMD) are crucial for preclinical evaluation of novel diagnostic procedures and treatment strategies. Pigs cloned from male cells lacking DMD exon 52 (DMD{Delta}52) resemble molecular, clinical and pathological hallmarks of DMD, but cannot be propagated by breeding due to death before sexual maturity. Therefore, female DMD+/- carriers were generated. A single founder animal had 11 litters with 29 DMDY/-, 34 DMD+/- as well as 36 male and 29 female wild-type (WT) offspring. Breeding with F1 and F2 DMD+/- carriers resulted in additional 114 DMDY/- piglets. The majority of them survived for 3-4 months, providing large cohorts for experimental studies. Pathological investigations and proteome studies of skeletal muscles and myocardium confirmed the resemblance of human disease mechanisms. Importantly, DMDY/- pigs reveal progressive fibrosis of myocardium and increased expression of connexin-43, associated with significantly reduced left ventricular fractional shortening and ejection fraction already at age 3 months. Furthermore, behavioral tests provided evidence for impaired cognitive ability of DMDY/- pigs. Our breeding cohort of DMD{Delta}52 pigs and standardized tissue repositories from DMDY/- pigs, DMD+/- carriers, and WT littermate controls provide important resources for studying DMD disease mechanisms and for testing novel diagnostic procedures and treatment strategies.

Source connections

Published article ↗

Explore related subjects

pathology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Stirm, M., Fonteyne, L. M., Shashikadze, B., Lindner, M., Chirivi, M., Lange, A., Kaufhold, C., Mayer, C., Medugorac, I., Kessler, B., Kurome, M., Zakhartchenko, V., Hinrichs, A., Kemter, E., Krause, S., Wanke, R., Arnold, G. J., Wess, G., Nagashima, H., Hrabe de Angelis, M., Flenkenthaler, F., Kobelke, L. A., Bearzi, C., Rizzi, R., Baehr, A., Matiasek, K., Walter, M. C., Kupatt, C., Ziegler, S., Bartenstein, P., Froehlich, T., Klymiuk, N., Blutke, A., Wolf, E.. 2021-09-03. A scalable, clinically severe pig model for Duchenne muscular dystrophy. https://doi.org/10.1101/2021.09.01.457562

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

NAE1-Dependent Protein Neddylation Preserves Endothelial Identity and Vascular Integrity

Background: Endothelial dysfunction is a central driver of cardiovascular and inflammatory diseases, yet the post-translational mechanisms that preserve endothelial homeostasis remain incompletely understood. Protein neddylation, the covalent conjugation of a ubiquitin-like modifier, regulates diverse cellular processes, yet its physiological role in the vascular endothelium remains unknown. This study investigated whether protein neddylation is required to preserve endothelial identity and vascular homeostasis. Methods: We generated tamoxifen-inducible endothelial-specific Nae1 knockout mice to inhibit neddylation and combined bulk RNA sequencing, single-cell and single-nucleus transcriptomics, quantitative proteomics, biochemical analyses, and gain- and loss-of-function approaches to define the role of endothelial neddylation in vascular homeostasis and inflammatory injury. Results: Endothelial-specific Nae1 deletion caused rapid mortality associated with vascular leakage, platelet accumulation, inflammation, and multi-organ injury. Multi-omics analyses demonstrated profound loss of endothelial identity, characterized by suppression of core endothelial programs and activation of inflammatory, procoagulant, and pyroptotic pathways. Single-cell analyses revealed progressive endothelial dysfunction culminating in depletion of the endothelial population and remodeling of the vascular niche. Mechanistically, endothelial neddylation deficiency activated gasdermin D (GSDMD)- and gasdermin E (GSDME)-dependent pyroptosis, whereas dual inhibition of GSDMD and GSDME markedly attenuated inflammatory transcriptomic remodeling, vascular injury, hepatocyte death, immune cell infiltration, and platelet accumulation. Translational analyses demonstrated reduced endothelial neddylation in experimental endotoxemia and decreased expression of neddylation pathway components in human atherosclerosis and COVID-19 datasets. Conversely, restoration of endothelial neddylation partially reversed inflammatory endothelial transcriptomic reprogramming in vivo. Conclusions: NAE1-dependent protein neddylation is an essential regulator of endothelial identity and vascular integrity. Loss of endothelial neddylation promotes gasdermin-dependent pyroptosis and thrombo-inflammatory vascular injury, whereas restoration of the neddylation pathway mitigates inflammatory endothelial dysfunction. These findings identify endothelial neddylation as a fundamental mechanism maintaining vascular homeostasis and a potential therapeutic target for cardiovascular and inflammatory diseases.

pathology↗

bioRxiv2026

Urine Recirculation During Normothermic Kidney Preservation Improves Energy Balance Involving the Urea and TCA Cycles

BackgroundDeceased donor kidneys experience cellular stress before undergoing transplantation. To alleviate this, preservation techniques were developed including normothermic machine perfusion (NMP). MethodsHere, we performed kidney NMP on discarded human kidneys for up to 24 hours. Volume management was regulated either by urine recirculation (UR) or urine replacement (NUR) with Ringers lactate. Notably, UR led to longer perfusion times compared to NUR. To investigate kidney NMP metabolic traits with or without UR over time, we performed longitudinal metabolomics analyses of perfusates of eight NMP kidneys by 2D-gas chromatography mass spectrometry (GCxGC-MS). ResultsOver 600 metabolic features were profiled, from which 74 were identified and 54 consistently quantified across 26 perfusate samples. Most notably, elevated levels of disaccharides (different isomers), hydroxy-purines, urea, glutamate and amino acids associated with the perfusion factor UR. Moreover, donor estimated glomerular filtration rate (eGFR) correlated significantly with the accumulation of lactate and gluconate. Most strikingly, lactate levels seemed to be more balanced in UR NMP perfusate, which otherwise accumulated rapidly within the first six hours. ConclusionsKidney preservation by NMP was previously limited to hours. UR-NMP affected kidney energy homeostasis, carbohydrate & purine metabolism and the Urea and TCA cycles. These insights add value to explain how urine-driven adaptations contribute to prolonged kidney function under NMP. Research in contextO_ST_ABSEvidence before this studyC_ST_ABSDeceased donors provide kidneys that experience cellular stress during retrieval and during transplantation. To attenuate tissue damage, preservation techniques were optimised to offer the most optimal environment for kidney organs retrieved from donation after circulatory death and brain death patients. Normothermic machine perfusion (NMP) of donor kidneys has been considered feasible, safe, offers viability assessment and contributes to favourable outcomes. However, there has been a limit in the length of time that this preservation method could be applied to kidney organs, thereby potentially restricting functional recovery of the kidney before organ transplantation. Added value of this studyBefore urine recirculation (UR) was introduced, NMP time was limited to a few hours. Remarkably, NMP with UR led to longer perfusion times and more stable kidney organ function as compared to no urine recirculation (NUR). In order to find out why, we compared urine recirculation with Ringers lactate solution for volume management during NMP on discarded human kidneys for up to 24 hours. Kidney NMP metabolic traits with or without UR over time were measured. More than 600 metabolic features were profiled, Most strikingly, lactate levels seemed to be more balanced in UR NMP perfusate of the course of 24 hours, which otherwise accumulated rapidly within the first six hours. Taken together, UR-NMP affected kidney energy metabolic pathways and rendering these more balanced. Ultimately, these urine-driven adaptations contribute to prolonged kidney function under NMP. Implications of all the available evidenceNMP as a procedure to preserve kidney organs including urine recirculation is now becoming standard in many transplantation units around the world. Our study provided a molecular snapshot of why kidney organs preserved in this way are maintained longer with a functionally active metabolism. This provides the basis for additional improvements leading to better kidney organ preservation, ultimately resulting in benefits for kidney transplant recipients.

pathology↗

bioRxiv2026

Non-HLA antibodies worsen the histological phenotype and prognosis of antibody mediated rejection in kidney allografts

IntroductionAntibody-mediated rejection (AMR) remains a leading cause of kidney allograft failure, with both HLA and non-HLA antibodies implicated in its pathogenesis. The contribution of non-HLA antibodies (non-HLA Abs) to microvascular inflammation (MVI) and graft outcome, particularly in cases lacking donor-specific anti-HLA antibodies (HLA-DSAs), remains incompletely understood. MethodsWe analyzed 571 post-transplant serum samples from 326 patients with histological features of AMR (AMRh) and 164 stable controls. Non-HLA Abs were detected using the previously developed Non-HLA Antibody Detection Immunoassay (NHADIA), and associations were examined with histological lesions, AMRh persistence, and graft outcomes. Biopsies were scored according to Banff 2022 criteria, and patients were stratified by HLA-DSA and NHADIA status. ResultsNHADIA values were significantly higher in AMRh patients compared to controls (P=0.0001), regardless of HLA-DSA status. NHADIA values correlated with the severity of glomerulitis, peritubular capillaritis and global MVI scores. In AMRh patients with HLA-DSAs, non-HLA Abs remained independently associated with MVI severity. Follow-up biopsies revealed persistent AMR lesions in patients with both HLA-DSAs and non-HLA Abs. Allograft survival was lowest in double-positive patients, and NHADIA positivity independently predicted graft loss (HR=2.25, 95% CI: 1.03-4.92, P=0.042). Incorporating NHADIA into the Banff classification reclassified 61% of AMRh cases as "double-positive AMRh," and identified new subgroups with significant prognostic differences. ConclusionPost-transplant detection of non-HLA antibodies identifies a distinct subset of AMR with more severe histology and worse graft prognosis, particularly when coexisting with HLA-DSAs. Integrating non-HLA Ab testing into current diagnostic frameworks may refine AMR classification and improve risk stratification. TRANSLATIONAL STATEMENTThis study highlights the clinical relevance of non-HLA antibodies, identified using our innovative endothelial cell-based assay (NHADIA), in kidney transplant recipients. Their presence is associated with more severe antibody-mediated rejection (AMR) and poorer graft outcomes, even in the absence of donor-specific HLA antibodies. Incorporating non-HLA antibody detection into routine post-transplant evaluation may allow clinicians to better identify high-risk patients, including those previously classified as DSA-negative AMR. This expanded immunological profiling refines AMR diagnosis, improves risk stratification, and opens new avenues for personalized immunosuppressive strategies, ultimately enhancing long-term graft survival and patient care.

pathology↗